SOX4-induced upregulation of ARHGAP9 promotes the progression of acute myeloid leukemia.
Sign Up to like & getrecommendations! Published in 2021 at "Drug development research"
DOI: 10.1002/ddr.21837
Abstract: Acute myeloid leukemia (AML) is the most common acute leukemia. Rho GTPase activating protein 9 (ARHGAP9) has been reported to be positively correlated with overall survival of AML patients, but the specific molecular function remains… read more here.
Keywords: myeloid leukemia; arhgap9; acute myeloid; aml ... See more keywords